Related Experiment Video
Updated: May 2, 2026

Development of an Ethanol-induced Fibrotic Liver Model in Zebrafish to Study Progenitor Cell-mediated Hepatocyte Regeneration
Published on: May 13, 2016
Cellular and molecular mechanisms in liver fibrogenesis
Erica Novo1, Stefania Cannito1, Claudia Paternostro1
1University of Torino, Dept. Clinical and Biological Sciences, Unit of Experimental Medicine and Clinical Pathology, Corso Raffaello 30, 10125 Torino, Italy.
Abstract:
Liver fibrogenesis is a dynamic and highly integrated molecular, tissue and cellular process, potentially reversible, that drives the progression of chronic liver diseases (CLD) towards liver cirrhosis and hepatic failure. Hepatic myofibroblasts (MFs), the pro-fibrogenic effector cells, originate mainly from activation of hepatic stellate cells and portal fibroblasts being characterized by a proliferative and survival attitude. MFs also contract in response to vasoactive agents, sustain angiogenesis and recruit and modulate activity of cells of innate or adaptive immunity. Chronic activation of wound healing and oxidative stress as well as derangement of epithelial-mesenchymal interactions are "major" pro-fibrogenic mechanisms, whatever the etiology. However, literature has outlined a complex network of pro-fibrogenic factors and mediators proposed to modulate CLD progression, with some of them being at present highly debated in the field, including the role of epithelial to mesenchymal transition and Hedgehog signaling pathways. Hypoxia and angiogenesis as well as inflammasomes are recently emerged as ubiquitous pro-inflammatory and pro-fibrogenic determinants whereas adipokines are mostly involved in CLD related to metabolic disturbances (metabolic syndrome and/or obesity and type 2 diabetes). Finally, autophagy as well as natural killer and natural killer-T cells have been recently proposed to significantly affect fibrogenic CLD progression.
Insights
Liver fibrogenesis, a key process in chronic liver disease, involves activated hepatic myofibroblasts and complex signaling pathways. Understanding these mechanisms is crucial for potentially reversing liver damage and preventing cirrhosis.
Area of Science:
- Hepatology
- Molecular Biology
- Cellular Biology
Background:
- Liver fibrogenesis drives chronic liver diseases (CLD) toward cirrhosis and failure.
- Hepatic myofibroblasts (MFs) are central effector cells, originating from activated hepatic stellate cells and portal fibroblasts.
- Key pro-fibrogenic mechanisms include wound healing, oxidative stress, and epithelial-mesenchymal interactions.
Purpose of the Study:
- To review the complex molecular and cellular network driving liver fibrogenesis.
- To highlight emerging and debated factors influencing CLD progression.
- To discuss the role of novel determinants like hypoxia, inflammasomes, and immune cells.
Main Methods:
- Literature review and synthesis of current research on liver fibrogenesis.
- Analysis of molecular, cellular, and tissue-level processes involved in fibrosis.
- Identification and discussion of key signaling pathways and cellular players.
Main Results:
- MFs exhibit proliferative, survival, contractile, and immune-modulating functions.
- Epithelial to mesenchymal transition and Hedgehog signaling are debated fibrogenic pathways.
- Hypoxia, angiogenesis, inflammasomes, adipokines, autophagy, and specific immune cells (NK, NKT) are emerging determinants.
Conclusions:
- Liver fibrogenesis is a complex, potentially reversible process involving multiple integrated mechanisms.
- Understanding these diverse factors is essential for developing targeted therapies for CLD.
- Further research into novel pathways and cellular interactions is needed to combat liver fibrosis effectively.
Related Concept Videos
Cirrhosis II: Pathophysiology
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
Cirrhosis I: Introduction
Introduction to Fibroblasts
Cell Specific Gene Expression
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...

